Similar Articles
New molecule in Parkinson’s disease treatment: Safinamide (monoamine oxidase-B plus inhibitor)
Murat Gültekin, Beyzanur Altıkulaç Ilikhan
DOI: 10.5606/phhb.dergisi.2025.49
Issue: 2025, Volume 28 - Issue 2-3
1683
884
A case of Parkinson’s disease with clinical deterioration specific to constipation periods
Funda Kaplan, Zehra Yavuz, Özlem Munis Bizpınar, Selim Selçuk Çomoğlu
DOI: 10.5606/phhb.dergisi.2025.33
Issue: 2025, Volume 28 - Issue 2-3
552
506
REM sleep behavior disorder in benign and malignant Parkinson’s disease: A comparative analysis of clinical and questionnaire-based findings
Nilay Padir Sensoz, Asya Kosereisoglu, Tülin Akturk, Banu Ozen Barut
DOI: 10.5606/phhb.dergisi.2026.73
Issue: 2026, Volume 29 - Issue 1
77
131